Eywa FDA Friday, March 8, 2019 0.00 Neutral

FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Eywa Pharma Inc

Eywa Pharma Inc. has obtained FDA approval for its generic hydrocodone bitartrate and acetaminophen oral tablets, a regulatory milestone expected to bolster the company's market presence and intensify competitive pricing within the established pain management sector.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day